Zane Ellen M's Form 4 filing
Haemonetics Corp (HAE) · filed Jul 28, 2026
- Accession no.
- 0000313143-26-000111
- Filed
- Jul 28, 2026, 5:02 PM ET
- Trade date
- Jul 24, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zane Ellen MCIK 0001369850 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Common Stock | AGrant or awardAcquired | +2,538 | –F2 | – | 21,911 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Referenced by the price of 1 transaction in Table I.